Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Ebola virus
Most Correlated Studies
- Reduced levels of CD45 (protein tyrosine phosphatase) protect mice from Ebola virus
- Peripheral blood from an ebola virus patient sampled over course of 270 days
- CD4+ T cells treated with Ebola virus variant Mayinga or with lipopolysaccharides
- Macrophages infected with Ebola or Reston Ebola virus or treated with lipopolysaccharides
- Ebola-infected non-human primates, response in PBMCs
Most Relevant Literature
- Ebola Virus Entry Inhibitors.
- Therapeutic Strategies against Ebola Virus Infection.
- Identification of novel Ebola virus inhibitors using biologically contained virus.
- Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence…
- Tracking ebolavirus genomic drift with a resequencing microarray.
Most Relevant Clinical Trials
- Investigational Therapeutics for the Treatment of People With Ebola Virus Disease
- Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up
- GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male E…
- Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)
- PREVAIL VII: Persistence of Ebola Virus in Aqueous Humor and Outcomes of Cataract Surgery in Survivo…
